In 2022, the FDA approved a new form of PrEP, called injectable cabotegravir (brand name Apretude). Apretude is a single, long-acting injection that is given every two months. It is highly effective at preventing HIV infection, just like oral PrEP.
Apretude may be a good option for people who:
- Have trouble taking oral PrEP as prescribed
- Prefer getting a shot every two months instead of taking a pill
- Have serious kidney disease that prevents use of oral PrEP medications
Apretude is not currently available at The Project of Primary Health Care. However, we do offer oral PrEP, as well as free and confidential HIV and STI testing. You can schedule an appointment for testing at phctheproject.org/free-testing.
If you are interested in learning more about injectable PrEP, please talk to your doctor.
Stigma-Free HIV Prevention
It is important to remember that HIV is a manageable chronic condition. People living with HIV can live long, healthy lives. It is also important to remember that HIV cannot be transmitted through casual contact.
We are committed to providing stigma-free HIV prevention services. We believe that everyone deserves access to the information and resources they need to stay healthy.
If you have any questions about HIV or PrEP, please do not hesitate to contact us. We are here to help.